$AXPNeutralLow

Is American Express Stock Underperforming the S&P 500?

American Express shares have trailed the S&P 500, according to the article. Still, analysts are moderately optimistic: 29 analysts rate the stock a “Moderate Buy,” and the consensus mean price target is $362.23, about 14.5% above current levels. The piece notes the author held no positions in the mentioned securities.

6/10
2/10
Low
Neutral
Published after-hours (16:15 UTC) as an analyst/relative-performance recap
Moderately supportive (Moderate Buy) but not a fresh catalyst

This is an analyst-consensus/relative-performance piece rather than a new company-specific catalyst.

Article frames American Express’ relative underperformance versus the S&P 500 and cites analyst “Moderate Buy” consensus plus a $362.23 mean target.

Limited near-term impact; any reaction is likely sentiment/positioning-driven rather than fundamentals.

Background

The article discusses AXP’s relative performance versus the S&P 500 and summarizes Wall Street consensus and price-target premium.

Why it matters

Because it lacks a new datapoint (earnings/guidance/deal/regulatory action), it is more useful for positioning than for forecasting a discrete catalyst-driven move.

Market relevance

Useful for gauging Street sentiment (Moderate Buy) but not a standalone trading trigger.

Market effects

Minimal; does not introduce new credit-card/consumer-finance fundamentals beyond generic analyst framing.

None indicated; compares to the S&P 500 without new macro/regional data.

Low; US-focused relative-performance and analyst-target discussion.

Alternative perspectives

Underperformance versus the S&P could reflect deteriorating relative fundamentals not captured by a “Moderate Buy” consensus.

The piece does not specify what drove the underperformance (spreads, charge-offs, travel demand, or FX), so traders should verify the latest operational drivers.

Key entities

  • American Express

    Subject of the article; consensus rating and mean price target are cited.

Related articles

$COFLow

Is Capital One Stock Underperforming the Dow?

Capital One said it is working through headwinds from Discover’s earlier credit policy cutbacks that have weighed on card growth. The company plans integration milestones for Discover and Brex, higher marketing and technology investment, and expansion of its digital-first banking and payments ecosystem. Analysts (23) still rate it a “Strong Buy,” with an average $255.54 price target, implying 43.9% upside.

$GSMed

Dow industrial average is surging led by financials in healthcare.

The Dow Jones Industrial Average rose about 930 points, or 1.84%, with 25 of 30 components higher and the index on pace for a record close. Financials led, including Goldman Sachs (+4.93%), JPMorgan (+3.64%) and American Express (+4.41%), while healthcare also supported gains such as UnitedHealth (+5.20%) and Merck (+3.73%). Decliners included Verizon (-2.44%) and IBM (-1.10%).

$AXPLow

Forget the "Magnificent Seven." This Financial Stock Could Be the Better Long-Term Bet.

The article argues that investors may look beyond the “Magnificent Seven” to American Express (AXP). It says American Express’ closed-loop model (payment network plus lending) and its premium cards are attracting younger consumers; millennials and Gen Z are described as the largest share of new card spending. Analysts expect ~14% annual earnings growth over 3–5 years, and the stock trades at about 18x 2026 earnings.